United States - English - NLM (National Library of Medicine)

time cap labs, inc - dimenhydrinate (unii: jb937per5c) (diphenhydramine - unii:8gts82s83m) - antiemetic   use for prevention and treatment of these symptoms associated with motion sickness: nauseavomitingdizziness

United States - English - NLM (National Library of Medicine)

carilion materials management - dimenhydrinate (unii: jb937per5c) (diphenhydramine - unii:8gts82s83m) - antiemetic for prevention and treatment of these symptoms associated with motion sickness: uses - nausea - vomiting - dizziness in children under 2 years of age unless directed by a doctor do not use - a breathing problem such as emphysema or chronic bronchitis - glaucoma - difficulty in urination due to enlargement of the prostate gland

United States - English - NLM (National Library of Medicine)

cardinal health - dimenhydrinate (unii: jb937per5c) (chlortheophylline - unii:ge2ua340fm) - purpose antiemetic for the prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness

United States - English - NLM (National Library of Medicine)

major pharmaceuticals - dimenhydrinate (unii: jb937per5c) (chlortheophylline - unii:ge2ua340fm) - purpose antiemetic for the prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness

United States - English - NLM (National Library of Medicine)

acme united corporation - dimenhydrinate (unii: jb937per5c) (chlortheophylline - unii:ge2ua340fm) - purpose antiemetic for prevention and treatment of nausea, vomiting or dizziness associated with motion sickness

United States - English - NLM (National Library of Medicine)

cvs pharmacy, inc. - dimenhydrinate (unii: jb937per5c) (chlortheophylline - unii:ge2ua340fm) - antiemetic for the prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness

Ireland - English - HPRA (Health Products Regulatory Authority)

hennig arzneimittel gmbh & co kg - cinnarizine; dimenhydrinate - tablet - 20 mg/40 milligram(s) - antivertigo preparations; cinnarizine, combinations

Australia - English - Department of Health (Therapeutic Goods Administration)

southern xp ip pty ltd - dimenhydrinate, quantity: 40 mg; cinnarizine, quantity: 20 mg - tablet, uncoated - excipient ingredients: hypromellose; croscarmellose sodium; purified talc; maize starch; magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica - short-term, symptomatic treatment of vertigo of various causes, in adults who have not responded to alternative treatments.

Australia - English - Department of Health (Therapeutic Goods Administration)

proqualix pty ltd - in administration - dimenhydrinate, quantity: 50 mg - tablet, uncoated - excipient ingredients: sodium sulfate; acacia; maize starch; carmellose sodium; magnesium stearate - new zealand: prevention and relief of motion sickness and treatment of vertigo, nausea or vomiting associated with: electroshock therapy, anaesthesia and surgery, labyrinthine disturbances, radiation sickness. singapore: prevention and relief of motion sickness and treatment of vertigo, nausea or vomiting. malaysia, hong kong, taiwan: prevention and relief of motion sicknessand treatment of vertigo, nausea or vomiting associated with : electroshock therapy, anaesthesia and surgery, labyrinthine disturbances, radiation sickness and post fenestration syndrome.

Australia - English - Department of Health (Therapeutic Goods Administration)

proqualix pty ltd - in administration - dimenhydrinate, quantity: 50 mg - tablet, uncoated - excipient ingredients: sodium sulfate; acacia; maize starch; carmellose sodium; magnesium stearate - new zealand: prevention and relief of motion sickness and treatment of vertigo, nausea or vomiting associated with: electroshock therapy, anaesthesia and surgery, labyrinthine disturbances, radiation sickness. singapore: prevention and relief of motion sickness and treatment of vertigo, nausea or vomiting. malaysia: prevention and relief of motion sickness and treatment of vertigo, nausea or vomiting associated with: electroshock therapy, anaesthesia and surgery, labyrinthine disturbances, radiation sickness and post fenestration syndrome.